Moringa Fertilité pour Elle
Food supplement declared in France, decision dated 27 October 2026
Moringa Fertilité pour Elle (RedMoringa) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- RedMoringa
- Food business operator placing the product on the market
- RedMoringa Srl
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 2 gélules par jour
- Directions for use
- Nous recommandons de prendre 2 gélules par jour. Conserver hermétiquement fermé dans un endroit frais et sec, à l'abri de la chaleur et des sources lumineuses. La date de péremption se réfère au produit correctement stocké dans un emballage non ouvert.
- Intended populations
- Men and women aged 18 and over, Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, Young children (aged 1 to 3), Pregnant women, Taking medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Menstrual cycles
Declaration 380495, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Moringa oleifera Lam. | Feuille | Poudre (de plantes séchées ou broyées) | 100 mg |
| Fucus vesiculosus L. | Thalle | Autre extrait sec | 75 mg |
Substances
| Name | Per day |
|---|---|
| resvératrol | 50 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Ubiquinone | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothénate de calcium | Acide pantothénique (vitamine B5) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| D-biotine | Biotine (vitamine B8) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Picolinate de chrome | Chrome | pas de limite (données insuffisantes) | 25 µg |
| Acide ptéroylmonoglutamique | Folates (vitamine B9) | 1,000 µg | 200 µg |
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Nicotinamide | Nicotinamide (vitamine B3) | 900 mg | 54 mg |
| Levure enrichie en sélénium | Sélénium | 255 µg | 50 µg |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Cyanocobalamine | Vitamine B12 | pas d'effet indésirable défini | dose annulled by the French Council of State in 2011 |
| Riboflavine | Vitamine B2 (riboflavine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
| Acétate de DL-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
| Gluconate de zinc | Zinc | 25 mg | 15 mg |
Additives
E464, E470b
Other ingredients
amidon de maïs
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Complément alimentaire pour adultes. Ne pas dépasser la dose journalière recommandée. En présence de certains états physiologiques ou pathologiques ou en association avec des traitements médicamenteux, consultez votre médecin. Tenir hors de portée des jeunes enfants. Les compléments alimentaires ne doivent pas être utilisés comme substitut d'une alimentation variée et équilibrée et d'un mode de vie sain. Ne convient pas aux femmes enceintes et allaitantes.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ubiquinone
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : RedMoringa
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.